Juvenile idiopathic arthritis(JIA), Systemic lupus erythematosus(SLE), Juvenile dermatomyositis(JDM), Sjogren'
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients diagnosed with a pediatric-onset rheumatic disease and treated at our institution, regardless of disease duration. 2) Patients who have been diagnosed with one or more of the following conditions:Juvenile idiopathic arthritis (JIA), Systemic lupus erythematosus (SLE), Juvenile dermatomyositis (JDM), Sjogren's syndrome (SS), Mixed connective tissue disease (MCTD), Systemic sclerosis (SSc), Behcet's disease, Vasculitis syndromes, Autoinflammatory diseases.
Exclusion criteria
Exclusion criteria: Patients (or their legal guardians) who decline participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Core clinical data including disease characteristics, disease activity, treatment patterns, treatment effectiveness, adverse events, and clinical outcomes obtained through retrospective chart review. | — |
Countries
Japan
Contacts
Nippon Medical School Pediatrics